Next Generation Sequencing Methods for Diagnosis of Epilepsy Syndromes

Area of Science:

• Neurology
• Genetics
• Molecular Biology

Background:

• Epilepsy is a complex neurological disorder with diverse causes, often with a significant genetic component.
• Approximately 70-80% of epilepsy cases have an identified genetic origin, involving hundreds of associated genes.
• Next-generation sequencing (NGS) offers powerful tools for analyzing these genetic factors.

Purpose of the Study:

• To review and compare commonly used NGS techniques for epilepsy genetic diagnostic testing.
• To assess the suitability of targeted gene panels, whole exome sequencing (WES), and whole genome sequencing (WGS) for clinical application.
• To provide information on workflows, sequencing depth, cost-effectiveness, and diagnostic outcomes for these techniques.

Main Methods:

• Review of current literature on next-generation sequencing (NGS) methodologies.
• Analysis of targeted gene panels, whole exome sequencing (WES), and whole genome sequencing (WGS) in the context of epilepsy genetics.
• Evaluation of factors such as workflow, sequencing depth, diagnostic yield, and cost-effectiveness.

Main Results:

• Different NGS techniques offer varying levels of diagnostic capability and cost-effectiveness for epilepsy genetic analysis.
• Understanding the specific applications and limitations of each NGS method is essential for accurate genetic diagnosis.
• The choice of NGS technique impacts the ability to identify the precise genetic etiology of epilepsy syndromes.

Conclusions:

• NGS techniques are indispensable for advancing the genetic diagnosis of epilepsy.
• A thorough understanding of NGS methods is required for effective clinical implementation in epilepsy diagnostics.
• Further evaluation of NGS techniques will optimize genetic testing strategies for epilepsy, improving diagnostic accuracy and patient outcomes.